BreezeBio

South San Francisco, CA · Founded 2016 · Privately Held (backing)

Developer of curative therapies designed for current gene therapy delivery challenges by systematically screening its proprietary nanoparticle library. BreezeBio is based in South San Francisco, CA and was founded in 2016. Its last reported valuation was $234 million in Feb 2026. It has raised $117 million.

Last reported valuation

$234.0M

Oct 2026

Priced at

—

Total raised

$117.0M

Last round

—

How much has BreezeBio raised?

$117.0Macross 0 recorded rounds

Free account

More of BreezeBio with a free account

·The complete investor list: 39 names
·Watch BreezeBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

BreezeBio investors

39 investors are on record for BreezeBio, including US National Science Foundation, Sequoia Capital, KB Investment and Korea Investment Partners. By type, the record holds 12 venture capital firms and 1 hedge fund.

For fundraisers

Raising for a company like BreezeBio?

39 investors have backed BreezeBio.

See all 39 investors →

Frequently asked about BreezeBio

How much has BreezeBio raised?: BreezeBio has raised $117.0M in total across 0 recorded funding rounds.